Literature DB >> 7537206

Central motor conduction in Hirayama disease.

U K Misra1, J Kalita.   

Abstract

The pathogenesis of Hirayama disease is usually attributed to microcirculatory disturbances in the anterior spinal artery territory, leading to segmental anterior horn cell loss and occasional lower limb hyperreflexia. In 7 patients with Hirayama disease, central motor conduction to upper (CMCT-ADM) and lower limbs (CMCT-TA) was evaluated. CMCT-TA was normal in all, but CMCT-ADM was marginally prolonged (8.4 msec, amplitude 0.8 mV) on one side only. Peripheral delay in the upper limbs was found in 2 patients (1 side each) which might be due to fall-out of anterior horn cells. In 2 patients with lower limb hyperreflexia, HM ratio, vibratory inhibition and reciprocal inhibition of soleus H reflex were also normal, suggesting lack of pyramidal dysfunction. Our results do not suggest any pyramidal dysfunction as a cause of lower limb hyperreflexia in Hirayama disease.

Entities:  

Mesh:

Year:  1995        PMID: 7537206     DOI: 10.1016/0924-980x(94)00246-4

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  9 in total

1.  Peripheral and segmental spinal abnormalities of median and ulnar somatosensory evoked potentials in Hirayama's disease.

Authors:  A Polo; M Curro' Dossi; A Fiaschi; G P Zanette; N Rizzuto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Effect of neck flexion on F wave, somatosensory evoked potentials, and magnetic resonance imaging in Hirayama disease.

Authors:  U K Misra; J Kalita; V N Mishra; R V Phadke; A Hadique
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

3.  A cervical myelopathy with a Hirayama disease-like phenotype.

Authors:  Chiara Cerami; Francesca Valentino; Federico Piccoli; Vincenzo La Bella
Journal:  Neurol Sci       Date:  2008-12-04       Impact factor: 3.307

4.  Hirayama's disease: an Italian single center experience and review of the literature.

Authors:  Valerio Vitale; Ferdinando Caranci; Chiara Pisciotta; Fiore Manganelli; Francesco Briganti; Lucio Santoro; Arturo Brunetti
Journal:  Quant Imaging Med Surg       Date:  2016-08

Review 5.  [Hirayama disease in Germany: case reports and review of the literature].

Authors:  J-S Kang; S Jochem-Gawehn; H Laufs; A Ferbert; P Vieregge; U Ziemann
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

6.  Hirayama disease is a pure spinal motor neuron disorder--a combined DTI and transcranial magnetic stimulation study.

Authors:  Kai Boelmans; Jörn Kaufmann; Sophie Schmelzer; Stefan Vielhaber; Malte Kornhuber; Alexander Münchau; Stephan Zierz; Charly Gaul
Journal:  J Neurol       Date:  2012-09-25       Impact factor: 4.849

7.  Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy.

Authors:  Angelo Ammendola; Antonio Gallo; Teresa Iannaccone; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

Review 8.  Nosology of juvenile muscular atrophy of distal upper extremity: from monomelic amyotrophy to Hirayama disease--Indian perspective.

Authors:  Kaukab Maqbool Hassan; Hirdesh Sahni
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

9.  The Quantitative Assessment of Imaging Features for the Study of Hirayama Disease Progression.

Authors:  Minghao Shao; Jun Yin; Feizhou Lu; Chaojun Zheng; Hongli Wang; Jianyuan Jiang
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.